aluates Reports

$ 0.0

Automative

Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-29W17486

Global Hydrogel based Drug Delivery Device Market Research Report 2024

BUY CHAPTERS

Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-29W17486

Report

October 2025

Pages:197

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Hydrogel-based Drug Delivery Device Market

The global Hydrogel-based Drug Delivery Device market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.

From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Hydrogel-based Drug Delivery Device leading manufacturers including AstraZeneca Plc., Columbia Laboratories Inc., Mylan, Teva Pharmaceuticals USA Inc., Blairex Laboratories Inc., ARx LLC., Endo International plc, BioDelivery Sciences International Inc., Indivior PLC, GSK Plc, etc., dominate supply; the top five capture approximately % of global revenue, with AstraZeneca Plc. leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Hydrogel-based Drug Delivery Device market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Hydrogel-based Drug Delivery Device Market Report

Report Metric	Details
Report Name	Hydrogel-based Drug Delivery Device Market
Segment by Type	Oral Buccal Rectal Vaginal Other
Segment by Application	Hospital Clinic Other
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca Plc., Columbia Laboratories Inc., Mylan, Teva Pharmaceuticals USA Inc., Blairex Laboratories Inc., ARx LLC., Endo International plc, BioDelivery Sciences International Inc., Indivior PLC, GSK Plc, Pfizer Inc., Aquestive Therapeutics Inc., ZIM LABORATORIES LIMITED, IntelGenx Corp., NEXGEL, Bliss GVS Pharma Ltd., Teika Pharmaceutical Co. Ltd., Medherant Limited, Galderma, Johnson & Johnson, Bausch and Lomb, Ferring B.V
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Hydrogel-based Drug Delivery Device study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Hydrogel-based Drug Delivery Device Market report?

Ans: The main players in the Hydrogel-based Drug Delivery Device Market are AstraZeneca Plc., Columbia Laboratories Inc., Mylan, Teva Pharmaceuticals USA Inc., Blairex Laboratories Inc., ARx LLC., Endo International plc, BioDelivery Sciences International Inc., Indivior PLC, GSK Plc, Pfizer Inc., Aquestive Therapeutics Inc., ZIM LABORATORIES LIMITED, IntelGenx Corp., NEXGEL, Bliss GVS Pharma Ltd., Teika Pharmaceutical Co. Ltd., Medherant Limited, Galderma, Johnson & Johnson, Bausch and Lomb, Ferring B.V

What are the Application segmentation covered in the Hydrogel-based Drug Delivery Device Market report?

Ans: The Applications covered in the Hydrogel-based Drug Delivery Device Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Hydrogel-based Drug Delivery Device Market report?

Ans: The Types covered in the Hydrogel-based Drug Delivery Device Market report are Oral, Buccal, Rectal, Vaginal, Other

1 Study Coverage

1.1 Introduction to Hydrogel-based Drug Delivery Device: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Hydrogel-based Drug Delivery Device Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Oral

1.2.3 Buccal

1.2.4 Rectal

1.2.5 Vaginal

1.2.6 Other

1.3 Market Segmentation by Application

1.3.1 Global Hydrogel-based Drug Delivery Device Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Hydrogel-based Drug Delivery Device Revenue Estimates and Forecasts 2020-2031

2.2 Global Hydrogel-based Drug Delivery Device Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Hydrogel-based Drug Delivery Device Sales Estimates and Forecasts 2020-2031

2.4 Global Hydrogel-based Drug Delivery Device Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Hydrogel-based Drug Delivery Device Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Hydrogel-based Drug Delivery Device Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Oral Market Size by Manufacturers

3.5.2 Buccal Market Size by Manufacturers

3.5.3 Rectal Market Size by Manufacturers

3.5.4 Vaginal Market Size by Manufacturers

3.5.5 Other Market Size by Manufacturers

3.6 Global Hydrogel-based Drug Delivery Device Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Hydrogel-based Drug Delivery Device Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Hydrogel-based Drug Delivery Device Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Hydrogel-based Drug Delivery Device Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Hydrogel-based Drug Delivery Device Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Hydrogel-based Drug Delivery Device Sales and Revenue by Type (2020-2031)

6.4 North America Hydrogel-based Drug Delivery Device Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Hydrogel-based Drug Delivery Device Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Hydrogel-based Drug Delivery Device Sales and Revenue by Type (2020-2031)

7.4 Europe Hydrogel-based Drug Delivery Device Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Hydrogel-based Drug Delivery Device Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Hydrogel-based Drug Delivery Device Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Hydrogel-based Drug Delivery Device Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Hydrogel-based Drug Delivery Device Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Hydrogel-based Drug Delivery Device Sales and Revenue by Type (2020-2031)

9.4 Central and South America Hydrogel-based Drug Delivery Device Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Hydrogel-based Drug Delivery Device Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Hydrogel-based Drug Delivery Device Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Hydrogel-based Drug Delivery Device Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Hydrogel-based Drug Delivery Device Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 AstraZeneca Plc.

11.1.1 AstraZeneca Plc. Corporation Information

11.1.2 AstraZeneca Plc. Business Overview

11.1.3 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.1.4 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales by Product in 2024

11.1.6 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales by Application in 2024

11.1.7 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales by Geographic Area in 2024

11.1.8 AstraZeneca Plc. Hydrogel-based Drug Delivery Device SWOT Analysis

11.1.9 AstraZeneca Plc. Recent Developments

11.2 Columbia Laboratories Inc.

11.2.1 Columbia Laboratories Inc. Corporation Information

11.2.2 Columbia Laboratories Inc. Business Overview

11.2.3 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.2.4 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales by Product in 2024

11.2.6 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales by Application in 2024

11.2.7 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales by Geographic Area in 2024

11.2.8 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device SWOT Analysis

11.2.9 Columbia Laboratories Inc. Recent Developments

11.3 Mylan

11.3.1 Mylan Corporation Information

11.3.2 Mylan Business Overview

11.3.3 Mylan Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.3.4 Mylan Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Mylan Hydrogel-based Drug Delivery Device Sales by Product in 2024

11.3.6 Mylan Hydrogel-based Drug Delivery Device Sales by Application in 2024

11.3.7 Mylan Hydrogel-based Drug Delivery Device Sales by Geographic Area in 2024

11.3.8 Mylan Hydrogel-based Drug Delivery Device SWOT Analysis

11.3.9 Mylan Recent Developments

11.4 Teva Pharmaceuticals USA Inc.

11.4.1 Teva Pharmaceuticals USA Inc. Corporation Information

11.4.2 Teva Pharmaceuticals USA Inc. Business Overview

11.4.3 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.4.4 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales by Product in 2024

11.4.6 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales by Application in 2024

11.4.7 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales by Geographic Area in 2024

11.4.8 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device SWOT Analysis

11.4.9 Teva Pharmaceuticals USA Inc. Recent Developments

11.5 Blairex Laboratories Inc.

11.5.1 Blairex Laboratories Inc. Corporation Information

11.5.2 Blairex Laboratories Inc. Business Overview

11.5.3 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.5.4 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales by Product in 2024

11.5.6 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales by Application in 2024

11.5.7 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales by Geographic Area in 2024

11.5.8 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device SWOT Analysis

11.5.9 Blairex Laboratories Inc. Recent Developments

11.6 ARx LLC.

11.6.1 ARx LLC. Corporation Information

11.6.2 ARx LLC. Business Overview

11.6.3 ARx LLC. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.6.4 ARx LLC. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 ARx LLC. Recent Developments

11.7 Endo International plc

11.7.1 Endo International plc Corporation Information

11.7.2 Endo International plc Business Overview

11.7.3 Endo International plc Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.7.4 Endo International plc Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Endo International plc Recent Developments

11.8 BioDelivery Sciences International Inc.

11.8.1 BioDelivery Sciences International Inc. Corporation Information

11.8.2 BioDelivery Sciences International Inc. Business Overview

11.8.3 BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.8.4 BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 BioDelivery Sciences International Inc. Recent Developments

11.9 Indivior PLC

11.9.1 Indivior PLC Corporation Information

11.9.2 Indivior PLC Business Overview

11.9.3 Indivior PLC Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.9.4 Indivior PLC Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Indivior PLC Recent Developments

11.10 GSK Plc

11.10.1 GSK Plc Corporation Information

11.10.2 GSK Plc Business Overview

11.10.3 GSK Plc Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.10.4 GSK Plc Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 GSK Plc Recent Developments

11.11 Pfizer Inc.

11.11.1 Pfizer Inc. Corporation Information

11.11.2 Pfizer Inc. Business Overview

11.11.3 Pfizer Inc. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.11.4 Pfizer Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Pfizer Inc. Recent Developments

11.12 Aquestive Therapeutics Inc.

11.12.1 Aquestive Therapeutics Inc. Corporation Information

11.12.2 Aquestive Therapeutics Inc. Business Overview

11.12.3 Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.12.4 Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 Aquestive Therapeutics Inc. Recent Developments

11.13 ZIM LABORATORIES LIMITED

11.13.1 ZIM LABORATORIES LIMITED Corporation Information

11.13.2 ZIM LABORATORIES LIMITED Business Overview

11.13.3 ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.13.4 ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.13.5 ZIM LABORATORIES LIMITED Recent Developments

11.14 IntelGenx Corp.

11.14.1 IntelGenx Corp. Corporation Information

11.14.2 IntelGenx Corp. Business Overview

11.14.3 IntelGenx Corp. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.14.4 IntelGenx Corp. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.14.5 IntelGenx Corp. Recent Developments

11.15 NEXGEL

11.15.1 NEXGEL Corporation Information

11.15.2 NEXGEL Business Overview

11.15.3 NEXGEL Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.15.4 NEXGEL Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.15.5 NEXGEL Recent Developments

11.16 Bliss GVS Pharma Ltd.

11.16.1 Bliss GVS Pharma Ltd. Corporation Information

11.16.2 Bliss GVS Pharma Ltd. Business Overview

11.16.3 Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.16.4 Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.16.5 Bliss GVS Pharma Ltd. Recent Developments

11.17 Teika Pharmaceutical Co. Ltd.

11.17.1 Teika Pharmaceutical Co. Ltd. Corporation Information

11.17.2 Teika Pharmaceutical Co. Ltd. Business Overview

11.17.3 Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.17.4 Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.17.5 Teika Pharmaceutical Co. Ltd. Recent Developments

11.18 Medherant Limited

11.18.1 Medherant Limited Corporation Information

11.18.2 Medherant Limited Business Overview

11.18.3 Medherant Limited Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.18.4 Medherant Limited Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.18.5 Medherant Limited Recent Developments

11.19 Galderma

11.19.1 Galderma Corporation Information

11.19.2 Galderma Business Overview

11.19.3 Galderma Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.19.4 Galderma Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.19.5 Galderma Recent Developments

11.20 Johnson & Johnson

11.20.1 Johnson & Johnson Corporation Information

11.20.2 Johnson & Johnson Business Overview

11.20.3 Johnson & Johnson Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.20.4 Johnson & Johnson Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.20.5 Johnson & Johnson Recent Developments

11.21 Bausch and Lomb

11.21.1 Bausch and Lomb Corporation Information

11.21.2 Bausch and Lomb Business Overview

11.21.3 Bausch and Lomb Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.21.4 Bausch and Lomb Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.21.5 Bausch and Lomb Recent Developments

11.22 Ferring B.V

11.22.1 Ferring B.V Corporation Information

11.22.2 Ferring B.V Business Overview

11.22.3 Ferring B.V Hydrogel-based Drug Delivery Device Product Models, Descriptions and Specifications

11.22.4 Ferring B.V Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2020-2025)

11.22.5 Ferring B.V Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Hydrogel-based Drug Delivery Device Industry Chain

12.2 Hydrogel-based Drug Delivery Device Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Hydrogel-based Drug Delivery Device Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Hydrogel-based Drug Delivery Device Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Hydrogel-based Drug Delivery Device Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Hydrogel-based Drug Delivery Device Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

List of Tables

Table 1. Global Hydrogel-based Drug Delivery Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Hydrogel-based Drug Delivery Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Hydrogel-based Drug Delivery Device Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Hydrogel-based Drug Delivery Device Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Hydrogel-based Drug Delivery Device Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Hydrogel-based Drug Delivery Device Sales by Region (2020-2025) & (K Units)

Table 8. Global Hydrogel-based Drug Delivery Device Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Hydrogel-based Drug Delivery Device Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Hydrogel-based Drug Delivery Device Sales Share by Manufacturers (2020-2025)

Table 12. Global Hydrogel-based Drug Delivery Device Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Hydrogel-based Drug Delivery Device by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydrogel-based Drug Delivery Device as of 2024)

Table 16. Global Hydrogel-based Drug Delivery Device Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Hydrogel-based Drug Delivery Device Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Hydrogel-based Drug Delivery Device Manufacturing Base and Headquarters

Table 19. Global Hydrogel-based Drug Delivery Device Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Hydrogel-based Drug Delivery Device Sales by Type (2020-2025) & (K Units)

Table 23. Global Hydrogel-based Drug Delivery Device Sales by Type (2026-2031) & (K Units)

Table 24. Global Hydrogel-based Drug Delivery Device Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Hydrogel-based Drug Delivery Device Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Hydrogel-based Drug Delivery Device ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Hydrogel-based Drug Delivery Device Sales by Application (2020-2025) & (K Units)

Table 29. Global Hydrogel-based Drug Delivery Device Sales by Application (2026-2031) & (K Units)

Table 30. Hydrogel-based Drug Delivery Device High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Hydrogel-based Drug Delivery Device Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Hydrogel-based Drug Delivery Device Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Hydrogel-based Drug Delivery Device ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Hydrogel-based Drug Delivery Device Growth Accelerators and Market Barriers

Table 37. North America Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Hydrogel-based Drug Delivery Device Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Hydrogel-based Drug Delivery Device Growth Accelerators and Market Barriers

Table 40. Europe Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Hydrogel-based Drug Delivery Device Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Hydrogel-based Drug Delivery Device Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Hydrogel-based Drug Delivery Device Growth Accelerators and Market Barriers

Table 45. Southeast Asia Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Hydrogel-based Drug Delivery Device Investment Opportunities and Key Challenges

Table 47. Central and South America Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Hydrogel-based Drug Delivery Device Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. AstraZeneca Plc. Corporation Information

Table 51. AstraZeneca Plc. Description and Major Businesses

Table 52. AstraZeneca Plc. Product Models, Descriptions and Specifications

Table 53. AstraZeneca Plc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. AstraZeneca Plc. Sales Value Proportion by Product in 2024

Table 55. AstraZeneca Plc. Sales Value Proportion by Application in 2024

Table 56. AstraZeneca Plc. Sales Value Proportion by Geographic Area in 2024

Table 57. AstraZeneca Plc. Hydrogel-based Drug Delivery Device SWOT Analysis

Table 58. AstraZeneca Plc. Recent Developments

Table 59. Columbia Laboratories Inc. Corporation Information

Table 60. Columbia Laboratories Inc. Description and Major Businesses

Table 61. Columbia Laboratories Inc. Product Models, Descriptions and Specifications

Table 62. Columbia Laboratories Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Columbia Laboratories Inc. Sales Value Proportion by Product in 2024

Table 64. Columbia Laboratories Inc. Sales Value Proportion by Application in 2024

Table 65. Columbia Laboratories Inc. Sales Value Proportion by Geographic Area in 2024

Table 66. Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device SWOT Analysis

Table 67. Columbia Laboratories Inc. Recent Developments

Table 68. Mylan Corporation Information

Table 69. Mylan Description and Major Businesses

Table 70. Mylan Product Models, Descriptions and Specifications

Table 71. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Mylan Sales Value Proportion by Product in 2024

Table 73. Mylan Sales Value Proportion by Application in 2024

Table 74. Mylan Sales Value Proportion by Geographic Area in 2024

Table 75. Mylan Hydrogel-based Drug Delivery Device SWOT Analysis

Table 76. Mylan Recent Developments

Table 77. Teva Pharmaceuticals USA Inc. Corporation Information

Table 78. Teva Pharmaceuticals USA Inc. Description and Major Businesses

Table 79. Teva Pharmaceuticals USA Inc. Product Models, Descriptions and Specifications

Table 80. Teva Pharmaceuticals USA Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Teva Pharmaceuticals USA Inc. Sales Value Proportion by Product in 2024

Table 82. Teva Pharmaceuticals USA Inc. Sales Value Proportion by Application in 2024

Table 83. Teva Pharmaceuticals USA Inc. Sales Value Proportion by Geographic Area in 2024

Table 84. Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device SWOT Analysis

Table 85. Teva Pharmaceuticals USA Inc. Recent Developments

Table 86. Blairex Laboratories Inc. Corporation Information

Table 87. Blairex Laboratories Inc. Description and Major Businesses

Table 88. Blairex Laboratories Inc. Product Models, Descriptions and Specifications

Table 89. Blairex Laboratories Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Blairex Laboratories Inc. Sales Value Proportion by Product in 2024

Table 91. Blairex Laboratories Inc. Sales Value Proportion by Application in 2024

Table 92. Blairex Laboratories Inc. Sales Value Proportion by Geographic Area in 2024

Table 93. Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device SWOT Analysis

Table 94. Blairex Laboratories Inc. Recent Developments

Table 95. ARx LLC. Corporation Information

Table 96. ARx LLC. Description and Major Businesses

Table 97. ARx LLC. Product Models, Descriptions and Specifications

Table 98. ARx LLC. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. ARx LLC. Recent Developments

Table 100. Endo International plc Corporation Information

Table 101. Endo International plc Description and Major Businesses

Table 102. Endo International plc Product Models, Descriptions and Specifications

Table 103. Endo International plc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Endo International plc Recent Developments

Table 105. BioDelivery Sciences International Inc. Corporation Information

Table 106. BioDelivery Sciences International Inc. Description and Major Businesses

Table 107. BioDelivery Sciences International Inc. Product Models, Descriptions and Specifications

Table 108. BioDelivery Sciences International Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. BioDelivery Sciences International Inc. Recent Developments

Table 110. Indivior PLC Corporation Information

Table 111. Indivior PLC Description and Major Businesses

Table 112. Indivior PLC Product Models, Descriptions and Specifications

Table 113. Indivior PLC Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Indivior PLC Recent Developments

Table 115. GSK Plc Corporation Information

Table 116. GSK Plc Description and Major Businesses

Table 117. GSK Plc Product Models, Descriptions and Specifications

Table 118. GSK Plc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. GSK Plc Recent Developments

Table 120. Pfizer Inc. Corporation Information

Table 121. Pfizer Inc. Description and Major Businesses

Table 122. Pfizer Inc. Product Models, Descriptions and Specifications

Table 123. Pfizer Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. Pfizer Inc. Recent Developments

Table 125. Aquestive Therapeutics Inc. Corporation Information

Table 126. Aquestive Therapeutics Inc. Description and Major Businesses

Table 127. Aquestive Therapeutics Inc. Product Models, Descriptions and Specifications

Table 128. Aquestive Therapeutics Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 129. Aquestive Therapeutics Inc. Recent Developments

Table 130. ZIM LABORATORIES LIMITED Corporation Information

Table 131. ZIM LABORATORIES LIMITED Description and Major Businesses

Table 132. ZIM LABORATORIES LIMITED Product Models, Descriptions and Specifications

Table 133. ZIM LABORATORIES LIMITED Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 134. ZIM LABORATORIES LIMITED Recent Developments

Table 135. IntelGenx Corp. Corporation Information

Table 136. IntelGenx Corp. Description and Major Businesses

Table 137. IntelGenx Corp. Product Models, Descriptions and Specifications

Table 138. IntelGenx Corp. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 139. IntelGenx Corp. Recent Developments

Table 140. NEXGEL Corporation Information

Table 141. NEXGEL Description and Major Businesses

Table 142. NEXGEL Product Models, Descriptions and Specifications

Table 143. NEXGEL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 144. NEXGEL Recent Developments

Table 145. Bliss GVS Pharma Ltd. Corporation Information

Table 146. Bliss GVS Pharma Ltd. Description and Major Businesses

Table 147. Bliss GVS Pharma Ltd. Product Models, Descriptions and Specifications

Table 148. Bliss GVS Pharma Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 149. Bliss GVS Pharma Ltd. Recent Developments

Table 150. Teika Pharmaceutical Co. Ltd. Corporation Information

Table 151. Teika Pharmaceutical Co. Ltd. Description and Major Businesses

Table 152. Teika Pharmaceutical Co. Ltd. Product Models, Descriptions and Specifications

Table 153. Teika Pharmaceutical Co. Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 154. Teika Pharmaceutical Co. Ltd. Recent Developments

Table 155. Medherant Limited Corporation Information

Table 156. Medherant Limited Description and Major Businesses

Table 157. Medherant Limited Product Models, Descriptions and Specifications

Table 158. Medherant Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 159. Medherant Limited Recent Developments

Table 160. Galderma Corporation Information

Table 161. Galderma Description and Major Businesses

Table 162. Galderma Product Models, Descriptions and Specifications

Table 163. Galderma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 164. Galderma Recent Developments

Table 165. Johnson & Johnson Corporation Information

Table 166. Johnson & Johnson Description and Major Businesses

Table 167. Johnson & Johnson Product Models, Descriptions and Specifications

Table 168. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 169. Johnson & Johnson Recent Developments

Table 170. Bausch and Lomb Corporation Information

Table 171. Bausch and Lomb Description and Major Businesses

Table 172. Bausch and Lomb Product Models, Descriptions and Specifications

Table 173. Bausch and Lomb Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 174. Bausch and Lomb Recent Developments

Table 175. Ferring B.V Corporation Information

Table 176. Ferring B.V Description and Major Businesses

Table 177. Ferring B.V Product Models, Descriptions and Specifications

Table 178. Ferring B.V Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 179. Ferring B.V Recent Developments

Table 180. Key Raw Materials Distribution

Table 181. Raw Materials Key Suppliers

Table 182. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 183. Milestones in Production Technology Evolution

Table 184. Distributors List

Table 185. Market Trends and Market Evolution

Table 186. Market Drivers and Opportunities

Table 187. Market Challenges, Risks, and Restraints

Table 188. Research Programs/Design for This Report

Table 189. Key Data Information from Secondary Sources

Table 190. Key Data Information from Primary Sources

List of Figures

Figure 1. Hydrogel-based Drug Delivery Device Product Picture

Figure 2. Global Hydrogel-based Drug Delivery Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Oral Product Picture

Figure 4. Buccal Product Picture

Figure 5. Rectal Product Picture

Figure 6. Vaginal Product Picture

Figure 7. Other Product Picture

Figure 8. Global Hydrogel-based Drug Delivery Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Other

Figure 12. Hydrogel-based Drug Delivery Device Report Years Considered

Figure 13. Global Hydrogel-based Drug Delivery Device Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Hydrogel-based Drug Delivery Device Revenue (2020-2031) & (US$ Million)

Figure 15. Global Hydrogel-based Drug Delivery Device Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 16. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Region (2020-2031)

Figure 17. Global Hydrogel-based Drug Delivery Device Sales (2020-2031) & (K Units)

Figure 18. Global Hydrogel-based Drug Delivery Device Sales (CAGR) by Region (2020-2031) (K Units)

Figure 19. Global Hydrogel-based Drug Delivery Device Sales Market Share by Region (2020-2031)

Figure 20. Top 5 and Top 10 Manufacturers Hydrogel-based Drug Delivery Device Sales Volume Market Share in 2024

Figure 21. Global Hydrogel-based Drug Delivery Device Revenue Market Share Ranking (2024)

Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 23. Oral Revenue Market Share by Manufacturer in 2024

Figure 24. Buccal Revenue Market Share by Manufacturer in 2024

Figure 25. Rectal Revenue Market Share by Manufacturer in 2024

Figure 26. Vaginal Revenue Market Share by Manufacturer in 2024

Figure 27. Other Revenue Market Share by Manufacturer in 2024

Figure 28. Global Hydrogel-based Drug Delivery Device Sales Market Share by Type (2020-2031)

Figure 29. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Type (2020-2031)

Figure 30. Global Hydrogel-based Drug Delivery Device Sales Market Share by Application (2020-2031)

Figure 31. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Application (2020-2031)

Figure 32. North America Hydrogel-based Drug Delivery Device Sales YoY (2020-2031) & (K Units)

Figure 33. North America Hydrogel-based Drug Delivery Device Revenue YoY (2020-2031) & (US$ Million)

Figure 34. North America Top 5 Manufacturers Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) in 2024

Figure 35. North America Hydrogel-based Drug Delivery Device Sales Volume (K Units) by Type (2020- 2031)

Figure 36. North America Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 37. North America Hydrogel-based Drug Delivery Device Sales Volume (K Units) by Application (2020-2031)

Figure 38. North America Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) by Application (2020-2031)

Figure 39. US Hydrogel-based Drug Delivery Device Revenue (2020-2031) & (US$ Million)

Figure 40. Canada Hydrogel-based Drug Delivery Device Revenue (2020-2031) & (US$ Million)

Figure 41. Mexico Hydrogel-based Drug Delivery Device Revenue (2020-2031) & (US$ Million)

Figure 42. Europe Hydrogel-based Drug Delivery Device Sales YoY (2020-2031) & (K Units)

Figure 43. Europe Hydrogel-based Drug Delivery Device Revenue YoY (2020-2031) & (US$ Million)

Figure 44. Europe Top 5 Manufacturers Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) in 2024

Figure 45. Europe Hydrogel-based Drug Delivery Device Sales Volume (K Units) by Type (2020-2031)

Figure 46. Europe Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) by Type (2020-2031)

Figure 47. Europe Hydrogel-based Drug Delivery Device Sales Volume (K Units) by Application (2020-2031)

Figure 48. Europe Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) by Application (2020-2031)

Figure 49. Germany Hydrogel-based Drug Delivery Device Revenue (2020-2031) & (US$ Million)

Figure 50. France Hydrogel-based Drug Delivery Device Revenue (2020-2031) & (US$ Million)

Figure 51. U.K. Hydrogel-based Drug Delivery Device Revenue (2020-2031) & (US$ Million)

Figure 52. Italy Hydrogel-based Drug Delivery Device Revenue (2020-2031) & (US$ Million)

Figure 53. Russia Hydrogel-based Drug Delivery Device Revenue (2020-2031) & (US$ Million)

Figure 54. Asia-Pacific Hydrogel-based Drug Delivery Device Sales YoY (2020-2031) & (K Units)

Figure 55. Asia-Pacific Hydrogel-based Drug Delivery Device Revenue YoY (2020-2031) & (US$ Million)

Figure 56. Asia-Pacific Top 8 Manufacturers Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) in 2024

Figure 57. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Volume (K Units) by Type (2020- 2031)

Figure 58. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 59. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Volume (K Units) by Application (2020-2031)

Figure 60. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) by Application (2020-2031)

Figure 61. Indonesia Hydrogel-based Drug Delivery Device Revenue (2020-2031) & (US$ Million)

Figure 62. Japan Hydrogel-based Drug Delivery Device Revenue (2020-2031) & (US$ Million)

Figure 63. South Korea Hydrogel-based Drug Delivery Device Revenue (2020-2031) & (US$ Million)

Figure 64. China Taiwan Hydrogel-based Drug Delivery Device Revenue (2020-2031) & (US$ Million)

Figure 65. India Hydrogel-based Drug Delivery Device Revenue (2020-2031) & (US$ Million)

Figure 66. Central and South America Hydrogel-based Drug Delivery Device Sales YoY (2020-2031) & (K Units)

Figure 67. Central and South America Hydrogel-based Drug Delivery Device Revenue YoY (2020-2031) & (US$ Million)

Figure 68. Central and South America Top 5 Manufacturers Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) in 2024

Figure 69. Central and South America Hydrogel-based Drug Delivery Device Sales Volume (K Units) by Type (2021-2031)

Figure 70. Central and South America Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) by Type (2020-2031)

Figure 71. Central and South America Hydrogel-based Drug Delivery Device Sales Volume (K Units) by Application (2020-2031)

Figure 72. Central and South America Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) by Application (2020-2031)

Figure 73. Brazil Hydrogel-based Drug Delivery Device Revenue (2020-2025) & (US$ Million)

Figure 74. Argentina Hydrogel-based Drug Delivery Device Revenue (2020-2025) & (US$ Million)

Figure 75. Middle East, and Africa Hydrogel-based Drug Delivery Device Sales YoY (2020-2031) & (K Units)

Figure 76. Middle East and Africa Hydrogel-based Drug Delivery Device Revenue YoY (2020-2031) & (US$ Million)

Figure 77. Middle East and Africa Top 5 Manufacturers Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) in 2024

Figure 78. Middle East and Africa Hydrogel-based Drug Delivery Device Sales Volume (K Units) by Type (2021-2031)

Figure 79. South America Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) by Type (2020-2031)

Figure 80. Middle East and Africa Hydrogel-based Drug Delivery Device Sales Volume (K Units) by Application (2020-2031)

Figure 81. Middle East and Africa Hydrogel-based Drug Delivery Device Sales Revenue (US$ Million) by Application (2020-2031)

Figure 82. GCC Countries Hydrogel-based Drug Delivery Device Revenue (2020-2025) & (US$ Million)

Figure 83. Turkey Hydrogel-based Drug Delivery Device Revenue (2020-2025) & (US$ Million)

Figure 84. Egypt Hydrogel-based Drug Delivery Device Revenue (2020-2025) & (US$ Million)

Figure 85. South Africa Hydrogel-based Drug Delivery Device Revenue (2020-2025) & (US$ Million)

Figure 86. Hydrogel-based Drug Delivery Device Industry Chain Mapping

Figure 87. Regional Hydrogel-based Drug Delivery Device Manufacturing Base Distribution (%)

Figure 88. Global Hydrogel-based Drug Delivery Device Production Market Share by Region (2020-2031)

Figure 89. Hydrogel-based Drug Delivery Device Production Process

Figure 90. Regional Hydrogel-based Drug Delivery Device Production Cost Structure

Figure 91. Channels of Distribution (Direct Vs Distribution)

Figure 92. Bottom-up and Top-down Approaches for This Report

Figure 93. Data Triangulation

Figure 94. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-29W17486

Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2031

FEATURED COMPANIES

Hydrogel-based Drug Delivery Device Market

Report Includes:

Scope of Hydrogel-based Drug Delivery Device Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Hydrogel-based Drug Delivery Device Market report?

What are the Application segmentation covered in the Hydrogel-based Drug Delivery Device Market report?

What are the Type segmentation covered in the Hydrogel-based Drug Delivery Device Market report?

FEATURED COMPANIES